Clinical Trial Update: Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 trial updating teriflunomide for steroid-resistant/relapse immune thrombocytopenia is in progress with unknown status in the listing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN